A dietary supplement for the management of patients with back pain
Background and study aims
Lumbar osteochondrosis is a disease of the lumbar (lower) spine caused by wear and tear on the intervertebral discs, vertebrae, vertebral joints or ligaments. Treatment is usually through pain and exercise therapy. The aim of this study is to investigate the 3-month intake of a dietary supplement as an accompanying measure to medical treatment. The food supplement, which has been sold in pharmacies for several years, is a combination of certain nutrients (collagen type II, hyaluronic acid, glucosamine,
bamboo extract, L-lysine, and vitamin C) that occur naturally in the intervertebral disc and are intended to improve back pain or at least contribute to the maintenance of the spinal column function.
Natural Products & Drugs GmbH
-
AT
-
2017On CPHI since
-
3Certificates
-
1 - 24Employees
Other Content from Natural Products & Drugs GmbH ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance